Pharma business info

Dr Reddy’s Laboratories , the country's No. 2 drug manufacturer by sales, registered a forecast-hitting 88% increase in quarterly net profit as sales in its main U.S. market increased over two-folds.

Nirmal Bang has suggested ‘hold’ rating on Glenmark Pharma to attain a price target of Rs 364.

British drug manufacturer AstraZeneca declared that it has decided to slash costs by shutting its Quebec research and development plant, annihilating 132 jobs.

Poland's retail pharma market posted a drop of 24% year on year during the last month to PLN 1.4 billion in gross retail prices.

Drug manufacturer Novartis will slash around 1,960 jobs in US during 2012 in expectancy of lower sales for two of its high blood pressure medications.

Savient Pharmaceuticals has roped in David Veitch President of Savient Europe with effect from January 16, 2012.

Glenmark Pharmaceuticals projects sales of its speciality biz, which concentrates on branded products, to develop by about 20% in the Indian market by the
coming three years (2015).

Fleming Pharmaceuticals has sold four of its well known brands, comprising Ocean nasal spray, to a division of a Canadian drug firm.

Glenmark Pharma has declared that they have bagged the DCGI (India) nod for conduct of the key research of Crofelemer in Acute Watery Diarrhoea sufferers.

Medicis Pharmaceutical Corp. has lifted up its viewpoint for profit this year by a couple of cents per share, even though the drug manufacturer turned down its direction for income owing to renegotiated deals.

Several equity research companies have altered their stock rankings and price objectives on scrips of Watson Pharmaceuticals during the past week.

Four out of five physicians think that patient care suffered during the existing year (2011) owing to NHS cutbacks, as per a novel review.